^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    CHECKvacc (CF33-hNIS-antiPDL1)

    i
    Associations
    News
    Trials
    Company:
    Imugene
    Drug class:
    PD-L1 inhibitor
    Related drugs:
    Associations
    News
    Trials